Source:http://linkedlifedata.com/resource/pubmed/id/19062178
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2009-5-14
|
pubmed:abstractText |
Clearance of the amyloid-beta peptide (A beta) as a remedy for Alzheimer's disease (AD) is a major target in on-going clinical trials. In vitro studies confirmed that A beta is taken up by rodent astrocytes, but knowledge on human astrocyte-mediated A beta clearance is sparse. Therefore, by means of flow cytometry and confocal laser scanning microscopy (CLSM), we evaluated the binding and internalization of A beta1-42 by primary human fetal astrocytes and adult astrocytes, isolated from nondemented subjects (n = 8) and AD subjects (n = 6). Furthermore, we analyzed whether alpha1-antichymotrypsin (ACT), which is found in amyloid plaques and can influence A beta fibrillogenesis, affects the A beta uptake by human astrocytes. Upon over night exposure of astrocytes to FAM-labeled A beta1-42 (10 microM) preparations, (80.7 +/- 17.7)% fetal and (52.9 +/- 20.9)% adult A beta-positive astrocytes (P = 0.018) were observed. No significant difference was found in A beta1-42 uptake between AD and non-AD astrocytes, and no influence of ApoE genotype on A beta1-42 uptake was observed in any group. There was no difference in the percentage of A beta-positive cells upon exposure to A beta1-42 (10 microM) combined with ACT (1,000:1, 100:1, and 10:1 molar ratio), versus A beta1-42 alone. CLSM revealed binding of A beta1-42 to the cellular surfaces and cellular internalization of smaller A beta1-42 fragments. Under these conditions, there was no increase in cellular release of the proinflammatory chemokine monocyte-chemoattractant protein 1, as compared with nontreated control astrocytes. Thus, primary human astrocytes derived from different sources can bind and internalize A beta1-42, and fetal astrocytes were more efficient in A beta1-42 uptake than adult astrocytes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid beta-Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E,
http://linkedlifedata.com/resource/pubmed/chemical/CCL2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL2,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/alpha 1-Antichymotrypsin,
http://linkedlifedata.com/resource/pubmed/chemical/amyloid beta-protein (1-42)
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1098-1136
|
pubmed:author | |
pubmed:copyrightInfo |
(c) 2008 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
978-88
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19062178-Adult,
pubmed-meshheading:19062178-Aged,
pubmed-meshheading:19062178-Aged, 80 and over,
pubmed-meshheading:19062178-Aging,
pubmed-meshheading:19062178-Alzheimer Disease,
pubmed-meshheading:19062178-Amyloid beta-Peptides,
pubmed-meshheading:19062178-Apolipoproteins E,
pubmed-meshheading:19062178-Astrocytes,
pubmed-meshheading:19062178-Brain,
pubmed-meshheading:19062178-Cells, Cultured,
pubmed-meshheading:19062178-Chemokine CCL2,
pubmed-meshheading:19062178-Female,
pubmed-meshheading:19062178-Genotype,
pubmed-meshheading:19062178-Humans,
pubmed-meshheading:19062178-Male,
pubmed-meshheading:19062178-Peptide Fragments,
pubmed-meshheading:19062178-Protein Binding,
pubmed-meshheading:19062178-alpha 1-Antichymotrypsin
|
pubmed:year |
2009
|
pubmed:articleTitle |
Binding and uptake of A beta1-42 by primary human astrocytes in vitro.
|
pubmed:affiliation |
Department of Clinical Chemistry, Pathology, The Alzheimer Centre, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. h.nielsen@vumc.nl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|